Piramal completes sale of domestic biz to Abbott

09 Sep 2010 Evaluate

Piramal Healthcare has completed the sale of its domestic formulations business to Abbott Healthcare for consideration of Rs 10,271 crore for the same. According to the agreement, Abbott had agreed to pay $2.12 billion (Rs 10,721 crore) upfront and the remaining amount in four annual instalment of $400 million.

As part of the agreement, Piramal will not engage in generic pharmaceutical business in the country for the next eight years. The completion of the deal would also lead to transfer of more than 5,000 employees of the domestic formulation business to Abbott.

crackcrack

Piramal Enterprises Share Price

795.55 -4.35 (-0.54%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Bajaj Finance 6702.50
Shriram Finance 2352.85
Aditya Birla Capital 223.85
SBI Cards AndPayment 692.15
Chola Invest & Fin. 1238.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.